With the NFL in its offseason, New England Patriots Safety Devin McCourty says he's focused on securing generational wealth for himself and other athletes through a new venture capital mission called Broad Street Ventures. Co-founded by Malcolm Jenkins of the New Orleans Saints and Ralonda Johnson, current president of the organization, the group looks to educate athletes while helping them gain financially.
"For us, we wanted to create a vehicle that would allow Black and brown investors to learn about venture capital but also have access to some of the best deals in the tech and consumer space," Johnson told Cheddar.
McCourty said that his close friendship with Jenkins is what spawned his decision to invest with Broad Street Ventures.
"We played in an all-star game coming out of high school and we do a lot off-the-field things together, and I think from there he started to talk about a vision of having NFL players having access to a different kind of wealth," he said.
Both grew up in New Jersey before going on to their collegiate and professional careers.
For NFL players, unlike in some other sports like the NBA and Major League Baseball, contracts are not guaranteed, the average length of a career is significantly fewer years, and as a result, players often have to find other means to secure finances for their futures. McCourty said that Broad Street Ventures allows all athletes to learn about venture capital investing.
Ralonda Johnson added that the group provides information sessions where potential investors can not only learn the ropes but also about emerging technologies.
"Not everyone [who] attends may invest or not, but just so that they at least have an understanding of tech investing. We'll go over from seed through late stage, just as much information that we can give them," she said.
For McCourty, Broad Street Ventures presents an opportunity for professional athletes to change the perception that the general public may have of them. He said with this opportunity, sports figures aren't limited to just making plays on the field. They can invest and lift up areas and industries that they are passionate about, offering fans a closer look at the human and not just the athlete.
Jared Walczak, Vice President of State Projects for the Tax Foundation, joins Cheddar News' Closing Bell, where he explains why a tax exemption for groceries does not benefit lower-income families as much as one would expect. He also makes the argument that a rate cut would actually be more beneficial.
Sourceful is an all-in-one platform for sourcing sustainable materials. The startup recently raised $20 million in a Series A round led by Index Ventures. Through its platform, Sourceful helps businesses find and design more eco-friendly packaging and reduce the carbon footprint of their supply chains. Wing Chan, Co-Founder and CEO of Sourceful, joined Cheddar News' Closing Bell to discuss.
If you did not attend Coachella and spent the weekend scrolling through Tiktok or Instagram, you probably saw a lot influencers comparing Revolve Festival to Fyre Fest.
Content creator Lars Gummer joins Cheddar News to discuss his experience at the festival.
Britt Reichborn-Kjennerud, Section Manager for E-Mobility & Demonstrations for Electric Vehicles, Con Edison and
Joe Morreale, Section Manager of EV Demo Projects and Managed Charging & E-Mobility & Demonstrations, Con Edison, join Cheddar News' Ken Buffa from the New York Auto Show to discuss Con Edison's Clean Energy Commitment and the goal to power New York with 100% clean energy through initiatives like the 'SmartCharge' and 'PowerReady' Programs.
Arthur Madrid, CEO of The Sandbox, and Steven Kolb, CEO of CFDA, join Cheddar News to discuss their partnership focused around fashion in the metaverse.
Ever walk into a CVS to pick up some gum, maybe some Chapstick, only to get hit with a ridiculously long receipt? It’s no secret that most CVS purchases come with these comically long receipts. But what might surprise you is that these long receipts are part of a marketing plan that's paying off big time for CVS.
Johnson & Johnson reported a miss on its Q1 earnings just shy of analyst expectations. The pharmaceutical giant also noted that it has an excess of COVID-19 vaccines and that it will be lowering its end-of-year earnings outlook for 2022.
